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3058Objective: The causes of constrictive pericarditis and predictors of perioperative outcome after pericardiectomy
have not been clearly elucidated, especially in Africa, where the disease characteristics differ from those in
developed countries. Furthermore, the effect of human immunodeficiency virus (HIV)/acquired immunodefi-
ciency syndrome (AIDS) on pericardial constriction and outcomes after surgery is unknown. We investigated
the causes of constrictive pericarditis, outcomes after pericardiectomy, and predictors of mortality in Cape
Town, South Africa, during a 22-year period of high HIV/AIDS prevalence.
Methods: A retrospective review of the medical records of all patients who had undergone pericardiectomy for
constrictive pericarditis at Groote Schuur Hospital from January 1, 1990 to December 31, 2012 was performed.
Results: Of 121 patients, 36 (29.8%) had proven tuberculosis, 74 (61.2%) had presumed tuberculosis, 6 (5%)
had idiopathic causes, and 5 (4%) had miscellaneous causes of constrictive pericarditis. Seventeen patients
(14%) died perioperatively with low cardiac output syndrome the main cause of mortality. On multivariable
analysis, serum sodium (hazard ratio, 0.88; 95% confidence interval, 0.80-0.97; P ¼ .009) and preoperative
NewYork Heart Association class IV (hazard ratio, 3.42; 95% confidence interval, 1.29-9.08; P¼ .014; vs com-
bined class I-III) were independent predictors of early mortality. Of the 121 patients, 14 (11.6%) were HIV pos-
itive, with a mean CD4 cell count of 284 133 cells/mL. No early deaths occurred in the HIV-positive patients.
Conclusions: Tuberculosis is the main cause of constrictive pericarditis in South Africa. Despite its efficacy at
relieving the symptoms of heart failure, pericardiectomy is associated with high perioperative mortality that was
not influenced byHIV status. NewYork Heart Association functional class IVand hyponatremia predict for early
mortality after pericardiectomy. (J Thorac Cardiovasc Surg 2014;148:3058-65)Supplemental material is available online.
Constrictive pericarditis (CP) is a treatable cause of heart
failure. Fibrosed, noncompliant parietal and visceral peri-
cardium impede ventricular filling in diastole, thereby
reducing the stroke volume and resulting in systemic
venous congestion.1 The causes of pericardial fibrosis
vary,2 with studies showing that infective causes are preva-
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The outcomes after pericardiectomy and the predictors of
mortality have been studied extensively in the developed
world,7-9 but only a few small studies have examined the
causes and outcomes of patients with constrictive
pericarditis requiring pericardiectomy in Africa.5,10
Owing to differences in disease patterns and resource
availability, the findings of studies conducted in the
developed world might not be an accurate reflection of
the experience of constrictive pericarditis requiring
pericardiectomy in Africa.
During the past 20 years, South Africa has seen an in-
crease in the prevalence of pulmonary and extrapulmonary
tuberculosis (TB), largely driven by increases in the inci-
dence and prevalence of human immunodeficiency virus
(HIV)/acquired immunodeficiency syndrome (AIDS).11
The effect of the increase in HIV/AIDS on the clinical char-
acteristics of constrictive pericarditis and the outcomes after
pericardiectomy are not known.
We conducted a study to examine the causes and determi-
nants of 30-day mortality, the functional outcomes, and the
effect of HIV/AIDS on the clinical profile and outcomes af-
ter pericardiectomy at Groote Schuur Hospital in Cape
Town, South Africa.gery c December 2014
Abbreviations and Acronyms
AIDS ¼ acquired immunodeficiency syndrome
CP ¼ constrictive pericarditis
HIV ¼ human immunodeficiency virus
HR ¼ hazard ratio
NYHA ¼ New York Heart Association
TB ¼ tuberculosis
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DMETHODS
A retrospective review of the medical records of all patients who had
undergone pericardiectomy for constrictive pericarditis at the Chris
Barnard Division of Cardiothoracic Surgery of Groote Schuur Hospital
was undertaken. The patients who had undergone pericardiectomy from
January 1, 1990, and December 31, 2012, were eligible for the present
study. The patient records were reviewed, and the data of interest
(demographic information, clinical signs and symptoms, hemodynamic
and laboratory data, operative techniques, and outcomes) were entered
into a standardized data capture sheet. The patients whose records could
not be found were excluded from the present study. The diagnosis of
constrictive pericarditis was determined from typical clinical and
echocardiographic findings, with confirmation of pericardial fibrosis and
constriction intraoperatively.6 Commonly encountered clinical features
included peripheral edema with hepatomegaly and ascites, pulsus
paradoxus, and pleural effusions. Echocardiography typically revealed
pericardial thickening, paradoxical septal motion, dilated inferior vena
cavae, and typical respiratory variation in Doppler flow across the mitral
and/or tricuspid valves. Cardiac catheterization and/or computed
tomography were done in cases of diagnostic uncertainty to confirm
pericardial thickening and constriction. All patients underwent surgery
by way of a median sternotomy, with particular care taken to free up
the entire ventricular epicardium, apex, and diaphragmatic surface of
the heart. Once freed, the pericardium was removed anteriorly, extending
laterally close to the phrenic nerves, with the posterior pericardium left in
situ after being freed from the epicardium (total pericardiectomy).
Any resection less than this was considered partial pericardiectomy.
Cardiopulmonary bypass was used at the discretion of the surgeon or
when hemodynamic instability prevented adequate exposure of the
adherent pericardium. Presumed TB as a cause for constrictive
pericarditis was defined as a history of pulmonary TB or the
initiation of empiric antituberculous therapy by the attending physician,
before pericardiectomy. Proven TB was defined as the presence of
Mycobacterium tuberculosis in pericardial tissue or fluid or sputum by
microscopy or culture. The presence of caseous pericardial tissue at
surgery was also considered confirmatory of TB. Perioperative mortality
was defined as death from any cause occurring during the index
hospitalization or within 30 days of surgery, even if the patient
had been discharged from the hospital. The University of Cape Town
Human Research Ethics Committee approved the study (reference no.
558/2012).
Statistical Analysis
Categorical data were compared using the chi-square test and
continuous data using the t test. The Kaplan-Meier method was used to
calculate probabilities of death and the log-rank test to compare these
probabilities by group. Cox proportional hazards regression models
were fitted to determine the risk factors associated with mortality.
In the present analysis, because of the small numbers, New York Heart
Association (NYHA) classes I to III were combined and modeled as
the baseline risk versus NHYA class IV. Variables significantly associatedThe Journal of Thoracic and Carwith the outcome were included in the final model. The proportionality
assumption of the Cox models was tested using ln[ln (survival)]
curves and regression of scaled Schoenfeld residuals on the functions
of time. All tests were 2-sided. Statistical analysis was conducted
using the Statistical Package for Social Sciences, version 20, (SPSS,
Chicago, Ill).RESULTS
A total of 128 patients underwent pericardiectomy for
constrictive pericarditis during the study period; 7 were
excluded because of missing records. Of the 121 patients
in the present study, 79 (65.3%) were men, and the
mean age was 41.3  16.1 years (range, 14-74). Two
patients developed recurrent constriction requiring repeat
pericardiectomy 2 months after the initial surgery. Total
pericardiectomy was possible in 105 patients (88.2%),
with 14 (11.8%) undergoing partial pericardiectomy.
Five patients (4.1%) underwent concomitant mitral valve
repair. One patient underwent concomitant aortic valve
replacement with coronary artery bypass grafting. The
baseline characteristics stratified by mortality status are
listed in Table 1.
Of the 121 patients, 110 (90.9%) had constrictive peri-
carditis due to either proven (36; 29.8%) or presumed
(74; 61.2%) TB. Of the remaining 11 patients, 6 (4.9%)
had idiopathic constrictive pericarditis and 5 had other
causes of pericarditis (Figure 1). The patient with
radiation-induced constrictive pericarditis had undergone
chest irradiation for Hodgkin’s lymphoma 20 years previ-
ously, and the patient with Kaposi sarcoma was HIV nega-
tive. The causes of constrictive pericarditis reported in
similar studies worldwide3,4,7-9,12-17 are listed in Table 2.
Of the 121 patients, 63 (52.1%) underwent diagnostic car-
diac catheterization, with only 1 case of coronary artery dis-
ease documented at coronary angiography. All 63 patients
had elevation and equalization of diastolic pressures, with
the dip-and-plateau configuration typical of constrictive
pericarditis. A total of 18 patients (14.9%) underwent car-
diac computed tomography scanning. The intraoperative
complications included 27 cases (22.3%) of inadvertent
myocardial wall or major vessel injury with bleeding,
tachyarrhythmias requiring cardioversion (n ¼ 6; 5%),
and phrenic nerve injury (n¼ 2; 1.7%). Low output cardiac
failure was the most common postoperative complication
(n ¼ 80; 66.1%), followed by sternal wound sepsis
(n¼ 9; 7.4%), other site sepsis (n¼ 9; 7.4%), acute kidney
injury (n ¼ 9; 7.4%), repeat thoracotomy for bleeding
(n ¼ 4; 3.3%), repeat thoracotomy for placement of
ventricular-assistive devices (n ¼ 2; 1.7%), respiratory
complications (n¼ 6; 5%), neuropsychiatric complications
(n¼ 5; 4.1%), and tachyarrhythmias (n¼ 3; 2.5%). No in-
traoperative mortality occurred. Seventeen patients (14%)
died postoperatively while still in hospital, 1 of whom had
undergone concomitant mitral valve repair. Nine of thesediovascular Surgery c Volume 148, Number 6 3059
TABLE 1. Baseline characteristics of study patients stratified by mortality status
Characteristic All (n ¼ 121) Alive (n ¼ 104) Died (n ¼ 17) P value
Mean age (y) 41.3  16.1 40.2  16.1 47.6  14.7 .08
Male sex 79 (65.3) 69 (66.3) 10 (58.8) .546
Cause of constrictive pericarditis .679
Tuberculosis 110 (90.9) 95 (91.3) 15 (88.2)
Other 11 (9.1) 9 (8.7) 2 (11.8)
Preoperative NYHA functional class .001
I 3 (2.5) 2 (1.9) 1 (5.9)
II 38 (31.4) 36 (34.6) 2 (11.8)
III 57 (47.1) 52 (50.0) 5 (29.4)
IV 23 (19) 14 (13.5) 9 (52.9)
Symptom duration (mo) 12.5  22.4 5.3  4.4 13.7  23.9 .154
HIV status .274
Positive 14 (11.6) 14 (13.5) 0 (0.0)
Negative 82 (67.8) 69 (66.3) 13 (76.5)
Unknown 25 (20.6) 21 (20.2) 4 (23.5)
Hypertension 12 (9.9) 9 (8.7) 3 (17.6) .25
Diabetes mellitus 3 (2.5) 3 (2.9) 0 (0.0) .478
Total daily diuretic dose* (mg) 119  101 109  71 174  192 .014
Weight (kg) 65  12 64.8  12.2 66.1  10.7 .715
SBP (mm Hg) 111  15 112  15 108  13 .262
DBP (mm Hg) 70  11 71  11 68  11 .288
Pulse rate (beats/min) 89  16 88  16 95  14 .091
Pulsus paradoxus 77 (63.6) 68 (65.4) 9 (52.9) .323
Ascites 92 (76) 77 (74) 15 (88.2) .204
Diastolic knock 64 (52.9) 57 (54.8) 7 (41.2) .297
Pleural effusion 96 (79.3) 83 (79.8) 13 (76.5) .753
Hepatomegaly 108 (89.3) 95 (91.3) 13 (76.5) .066
Pericardial calcificationy 28 (23.1) 25 (24.0) 3 (17.6) .562
Atrial fibrillation 10 (8.3) 7 (6.7) 3 (17.6) .13
Low QRS amplitude 77 (63.6) 63 (60.6) 14 (82.4) .084
LVEF (%) 57  11 57  11 58  14 .704
Hemoglobin (g/dL) 13.1  1.7 13.1  1.7 13.0  1.5 .759
Serum sodium (mmol/L) 137  5 138  4 133  7 <.0001
Serum creatinine (mmol/L) 83  23 81  18 99  38 .002
Total pericardiectomyz 105 (88.2) 93 (90.3) 12 (75) .077
Cardiopulmonary bypass 20 (16.5) 15 (14.4) 5 (29.4) .123
Postoperative inotrope use 80 (66.1) 63 (60.6) 17 (100) .001
Postoperative ICU stay (d) 3.4  2.3 3.4  1.8 3.5  4.4 .96
Data presented as mean  standard deviation for continuous variables and n (%) for categorical variables. NYHA, New York Heart Association; HIV, human immunodeficiency
virus; SBP, systolic blood pressure;DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction (measured on echocardiogram or at cardiac catheterization); ICU, inten-
sive care unit. *Furosemide. yFound on chest radiograph or at cardiac catheterization. zAnterior pericardium excised between phrenic nerves and posterior pericardium freed;
pericardiectomy completeness could not be ascertained for 1 patient in each subgroup.
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Low output cardiac failurewas directly or indirectly respon-
sible for the death of 11 patients, and acute kidney injury
was implicated in the death of 6 patients. Postoperative
sepsis was implicated in 4 deaths and postoperative
bleeding, rapid atrial fibrillation, and respiratory failure in
1 each. One patient’s death was sudden and unexplained,
and the cause of death for 2 patients was not apparent
from their medical records. Figure 2 shows the overall
Kaplan-Meier survival plot for the study population. The
30-day survival rate in the present study was 86%. The3060 The Journal of Thoracic and Cardiovascular Surcompleteness of pericardiectomy did not have any effect
on perioperative mortality (hazard ratio [HR], 1.74; 95%
confidence interval [CI], 0.61-4.97; P ¼ .077). The opera-
tive period did not affect perioperative mortality (1990-
2000 mortality, 8 of 46 [17%]; 2001-2012 mortality, 9 of
75 [12%]; P¼ .41). No difference was seen in mortality be-
tween patients with proven versus those with presumed TB
pericarditis (P ¼ .632).
On univariable Cox proportional hazards regression anal-
ysis, the variables significantly associated with periopera-
tive mortality were preoperative NYHA class (class IV,gery c December 2014
FIGURE 1. Causes of constrictive pericarditis in 121 patients who under-
went pericardiectomy (1990-2012). TB, Tuberculosis.
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DHR, 4.99; 95%CI, 1.92-13.03; P¼ .001, vs combined class
I-III), preoperative total daily dose of diuretic (furosemide;
HR, 1.003; 95% CI, 1.001-1.006; P ¼ .019), preoperative
serum creatinine (HR, 1.09; 95% CI, 1.01-0.03;
P ¼ .002), and preoperative serum sodium (HR, 0.86;
95% CI, 0.80-0.93; P<.0001). On multivariable analysis,
serum sodium (HR, 0.88; 95% CI, 0.80-0.97; P ¼ .009)
and preoperative NYHA class (class IV, HR, 3.42; 95%
CI, 1.29-9.08; P¼ .014, vs combined class I-III) were inde-
pendent predictors of early mortality (Table 3).
Of the 96 patients tested, 14 (14.6%) were HIV positive
on serology, and the HIV status of 25 of the 121 study pa-
tients (20.6%) was unknown. Most of the patients with an
unknown HIV status had undergone pericardiectomy in
the early 1990s before the advent of routine preoperative
HIV testing. The baseline characteristics of the HIV-
positive and HIV-negative patients are listed in Table E1.
Women were overrepresented in the HIV-positive group
(8 women [57.1%] vs 6 men [42.9%]; P ¼ .024), and the
hemoglobin (mean, 13.2  1.7 vs 12.1  2.0 g/dL;
P ¼ .031) and serum creatinine (mean, 86  25 vs 68  9
mmol/L; P ¼ .012) were significantly lower in the HIV-
positive patients than in the HIV-negative patients. No
HIV-positive patients underwent surgery on cardiopulmo-
nary bypass. The average CD4 count at surgery was 284
 133 cells/mL (range, 50-435). Of the 14 HIV-positive pa-
tients, 9 (64.3%) were taking combination antiretroviral
therapy at surgery. No perioperative deaths occurred in
the HIV-positive group.
The preoperative and 30-day postoperative NYHA func-
tional status was available for 73 (60.3%) of the 121 pa-
tients (Figure E1). Most showed improvement in
functional status (P< .0001), with most changing from
NYHA class II to class I (n ¼ 25, 34.2%) and NYHA class
III to class I (n ¼ 21, 28.8%). Seven patients (9.6%) re-
mained in the same functional class, and 2 (2.7%) hadThe Journal of Thoracic and Carexperienced deterioration in their functional status at 30
days after pericardiectomy. Before surgery, most of the pa-
tients had NYHA class III symptoms (n ¼ 35, 47.9%).
However, postoperatively, most reported class I symptoms
30 days after surgery (n ¼ 50, 68.5%).
DISCUSSION
We studied the etiology of constrictive pericarditis and
early outcomes after pericardiectomy in 121 patients during
a 22-year period at a single center from Sub-Saharan Africa.
The period under review covered a time during which TB
and HIV/AIDS were on the ascendency in this region. To
the best of our knowledge, this is the first large study of
the etiology and predictors of perioperative outcomes of
constrictive pericarditis in the HIV/AIDS era in Africa.
Our results have some variation from those reported in
recent similar series covering the same subject.7-9,14,17,18
Although our findings are relevant to practitioners in
South Africa and other developing countries, the
globalization of health implies that practitioners in North
America and Europe are likely to treat increasing
numbers of immigrants and refugees with TB and its
sequelae, such as constrictive pericarditis.19
Of the 121 patients in our study, 110 (90.9%) had either
proven or presumed TB as a cause of their constrictive peri-
carditis. This is greater than that reported in other series
from China, Ghana, India, South Korea, and Turkey, where
TB remains a major cause of constrictive pericarditis (Table
2). TB accounted for 65% of the patients undergoing peri-
cardiectomy for constrictive pericarditis in a study from
China,14 with studies from Ghana, India, South Korea,
and Turkey revealing a prevalence rate of 63.6%, 61%,
42.4%, and 38%, respectively.3-5,13 Only 36 (32.7%) of
the 110 patients had a proven diagnosis of tuberculous-
constrictive pericarditis. This difference highlights the diag-
nostic difficulty faced by clinicians in resource-limited
settings where TB is endemic—without recourse to
advanced diagnostic techniques to determine the etiology
of constrictive pericarditis, the clinician, armed only with
knowledge of the background high prevalence of TB, is
forced to treat empirically for TB to avoid the technical dif-
ficulty and associated morbidity and mortality that comes
with performing pericardiectomy on patients with active
or untreated tuberculous pericarditis.10 This common sce-
nario is a likely contributor of the large number of cases
of TB constrictive pericarditis seen in our series and might
mean that TB has been overreported as a cause of constric-
tive pericarditis in South Africa. Fennell,10 in an earlier
South African study, alluded to similar difficulties and a
similar course of action in managing constrictive pericar-
ditis. He had surmised that all 109 patients in his cohort
had TB constrictive pericarditis.10 Histologic examination
of most specimens recovered at pericardiectomy showed
nonspecific chronic inflammation and did not solve thisdiovascular Surgery c Volume 148, Number 6 3061
TABLE 2. Causes of constrictive pericarditis, perioperative mortality, and determinants of mortality after pericardiectomy for constrictive
pericarditis in a selection of large studies3,4,7-9,12-17
Investigator Country
Study
period Patients (n) Constrictive pericarditis etiology
Perioperative
mortality (%)
Predictors of perioperative
mortality
Bashi et al3 India 1954-1985 118 TB (61%) 16 Preoperative NYHA class III and IV
Bertog et al8 USA 1977-2000 163 Idiopathic (46%), previous cardiac
surgery (37%), after RT (9%),
miscellaneous (8%)
6.1 —
Cinar et al12 Turkey 1990-2005 70 TB (100%) 8.6 Ascites, symptom duration
Tokuda et al16 Japan 2008-2012 346 — 10 Moderate-severe chronic lung
disease, renal failure, preoperative
NYHA class IV, previous cardiac
surgery, CPB*
George et al9 USA 1995-2010 98 Idiopathic (45%), previous cardiac
surgery (31%), after RT (17%),
tumor (3%), infection (1%),
hemopericardium (1%), asbestos
(1%)
7.1 CPB
Ling et al7 USA 1985-1995 135 Idiopathic (33%), previous cardiac
surgery (18%), pericarditis (16%),
after RT (13%), connective tissue
disease (7%), infection (3%),
miscellaneous (10%)
6 —
McCaughan et al15 USA 1936-1982 231 Idiopathic (73%), pericarditis (10%),
infection (6%), after RT (5%),
previous cardiac surgery (2%),
connective tissue disease (2%),
miscellaneous (2%)
14 Preoperative NYHA class IV
Szabo et al17 Germany 1988-2012 89 Idiopathic (55%), previous cardiac
surgery (23.6%), after RT (5.6%),
TB (5.6%), uremia (4.5%),
inflammatory (3.5%), after MI
(2.2%)
7 —
Lin et al14 China 2005-2010 51 TB (65%), idiopathic (25%),
previous cardiac surgery (6%),
connective tissue disease (2%),
after trauma (2%)
3.9 —
Arsan et al4 Turkey 1983-1993 105 TB (38%), malignancy (15%),
uremia (11.4%), connective tissue
disease (10.5%)
10.5 —
Kang et al13 South Korea 1996-2010 85 Idiopathic (57.6%), TB (42.4%) 1.2 —
TB, Tuberculosis; NYHA, New York Heart Association; RT, radiotherapy; CPB, cardiopulmonary bypass; MI, myocardial infarction. *Predictors of perioperative mortality or
major morbidity.
Acquired Cardiovascular Disease Mutyaba et al
A
C
Ddiagnostic dilemma.10 Despite the possibility that TB peri-
carditis as a cause of constrictive pericarditis might have
been overreported in the present study, little doubt exists
that TB remains the leading cause of effusive and subse-
quent constrictive pericarditis in South Africa. A local study
found TB accounted for 69.5% of large pericardial effu-
sions in this region of South Africa.20 The use of imaging
studies such as computed tomography or magnetic reso-
nance imaging might help to reduce diagnostic uncertainty
in situations in which active pericarditis or myopericarditis,
such as can occur in active TB pericarditis, needs to be
excluded.21 It is also worth noting the rarity with which3062 The Journal of Thoracic and Cardiovascular Surmediastinal irradiation, autoimmune diseases, and other
causes of constrictive pericarditis commonly reported in
developed countries are seen in our setting (Table 2).7,8,17
Only 1 patient had undergone pericardiectomy for
radiation-induced constrictive pericarditis in 22 years at
our center compared with 17 patients in 10 years in the
study by Ling and colleagues.7
Our study found greater perioperative mortality than that
reported in similar series worldwide. We have reported a
30-day mortality rate of 14%, but others have reported mor-
tality rates in the range of 6% to 10%.7,12,16,17 The only
recent study with similar perioperative mortality was thatgery c December 2014
FIGURE 2. Kaplan-Meier 30-day survival plot; 17 of 121 patients (14%)
died within 30 days of pericardiectomy.
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Dby Ariyoshi and colleagues,22 which reported 12.5% mor-
tality but only among 16 patients. Also, McCaughan and
colleagues15 reported a perioperative mortality rate of
14% in a cohort of 231 patients from 1932 to 1986. Bashi
and colleagues3 reported a 16% perioperative mortality
rate in 118 patients who had undergone surgery from
1954 to 1985. The mortality in our study was not influenced
by the decade during which pericardiectomy was per-
formed. Unlike Chowdhury and colleagues,23 who found
partial pericardiectomy to predict for perioperative mortal-
ity, we found no difference in outcomes between those who
underwent total versus partial pericardiectomy using a sur-
gical technique similar to that used by Chowdhury and col-
leagues.23 Kang and colleagues,13 who reported on total and
partial pericardiectomy just as we have, also found no dif-
ference in outcomes.
We found the preoperative NYHA class to be indepen-
dently associated with perioperative mortality in our popu-
lation. Compared with preoperative combined NYHA I to
III functional status, patients with preoperative NYHA class
IV symptoms had a greater risk of perioperative death.
Other investigators have found a similar statistically signif-
icant association between preoperative NYHA IV status
and early mortality. Tokuda and colleauges16 reported a
3.85 greater odds of early death (P<.0001), and TirilomisTABLE 3. Univariate and multivariate Cox proportional hazards regressi
Factor
Univariate analys
HR (95% CI)
Serum sodium 0.86 (0.80-0.93)
Serum creatinine 1.09 (1.01-1.03)
Total daily dose (furosemide) 1.003 (1.00-1.006)
NYHA class
I-III 1
IV 4.99 (1.92-13.03)
HR, Hazard ratio; CI, confidence interval; NYHA, New York Heart Association.
The Journal of Thoracic and Carand colleagues24 reported an increased risk of death with
preoperative NYHA class IV symptoms (P<.01). Preoper-
ative NYHA class IV signifies more severe disease with a
greater degree of cardiac dysfunction that is more likely
to result in perioperative morbidity and mortality. In studies
of the long-term outcomes after pericardiectomy, preopera-
tive NYHA class IV was also found to be a predictor of
mortality.7,17
We have also found preoperative serum sodium to be
inversely associated with 30-day mortality, with lower
serum sodium levels associated with increased early mor-
tality. Bertog and colleagues8 also reported that low serum
sodium was associated with greater overall mortality in
their cohort of 163 patients. Low serum sodium is a reflec-
tion of severe fluid overload in the presence of gross heart
failure (dilutional hyponatremia) or the use of higher
doses of diuretic, such as occurred in our study, in patients
with severe fluid overload. The latter assertion is
supported by our finding that higher doses of diuretic
(furosemide) and higher serum creatinine were also
associated with mortality on univariable analysis—the 3
findings are likely to coexist in a patient with severe fluid
overload; that is, a higher dose of diuretic (which is likely
to cause low sodium and renal impairment with an
increasing serum creatinine) will be used to treat a patient
with severe fluid overload. Alternatively, hyponatremia re-
flects a generalized electrolyte imbalance as a marker of
severe illness such as would occur in the syndrome of
inappropriate antidiuretic hormone or sick cell syn-
drome.25 Although not found in our study, other factors
associated with 30-day mortality have included left ven-
tricular dysfunction,26 the use of cardiopulmonary
bypass,9,16 and preoperative renal failure.16
Low output cardiac failure was a major contributor to
mortality in our series, occurring in 11 (64.7%) of 17 pa-
tients who died. It was also found to be the predominant
cause of perioperative death in other studies.7,8,14,27 Low
output cardiac failure mainly results from the presence of
myocardial atrophy and/or fibrosis, especially in cases of
long-standing constriction.6 Despite the use of inotropes,
intra-aortic balloon pump, and fluid resuscitation, a signifi-
cant number of deaths associated with low output cardiac
failure still occurred in our study.on models of factors associated with mortality
is Multivariate analysis
P value HR (95% CI) P value
<.0001 0.88 (0.80-0.97) .009
.002 1.01 (0.99-1.03) .089
.02 1.00 (0.99-1.01) .312
.001 .014
1
3.42 (1.29-9.08)
diovascular Surgery c Volume 148, Number 6 3063
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idence of HIV infection. To the best of our knowledge, this
is the first study to document the prevalence, clinical char-
acteristics, and outcomes of HIV-positive patients undergo-
ing pericardiectomy for constrictive pericarditis. A recent
nationwide study in the United States had <10 HIV-
positive patients of a population of 3847 undergoing peri-
cardiectomy.28 The low frequency of HIV in our cohort
might reflect the apparent protective effect of HIV infection
on the progression to constrictive pericarditis.12,29-32 All the
HIV-positive patients in our study had TB pericarditis as the
cause of their constrictive pericarditis (6 proven TB, 8 pre-
sumed TB). The average CD4 count was 284 cells/mL, indi-
cating some degree of immunologic integrity and thereby
increasing the likelihood of progression to pericardial
constriction. A CD4 count of 284 cells/mL is higher than
what we commonly see in other cases of extrapulmonary
TB andmight have resulted from the use of combination an-
tiretroviral therapy, which, at 64.3%, was greater than that
seen in the background population during most of the study
period.33
The only significant differences between the HIV-
positive and -negative populations were in sex (more female
HIV-positive patients), a lower (but still largely normal) he-
moglobin in the HIV-positive group, and a lower creatinine,
which might reflect the reduced body habitus usually asso-
ciated with HIV infection—these differences did not affect
the outcomes between the 2 groups. No early deaths
occurred in the HIV-positive population. The high preva-
lence of TB in our study and in the pre-HIV era study by
Fennell10 suggests that the advent of HIV/AIDS did not
affect the causality pattern of constrictive pericarditis in
South Africa. Fennell10 reported in-hospital mortality of
3%, and we had 30-day mortality of 14%. The outcome re-
sults of our study and those from Fennell10 are not compa-
rable because of differences in the methods of the 2 studies.
The present study has shown that when TB constrictive
pericarditis does occur in HIV-positive patients, the clinical
characteristics and perioperative outcomes will be compa-
rable to those for HIV-negative patients.
Despite the greater than commonly reported periopera-
tive mortality, we have shown that most survivors experi-
enced marked improvement in their effort tolerance, as
measured by the NYHA classification. Most of our patients
for whom data were available at both measurement points
had improved from NYHA class II and III preoperatively
to class I at 30 days after surgery (P<.0001). Ling and col-
leagues7 reported similar improvements in a cohort of 93
late survivors after pericardiectomy.
Study Limitations
Our study was limited by the small number of missing pa-
tient records and missing data from the available patient re-
cords owing to the retrospective study design. Despite these3064 The Journal of Thoracic and Cardiovascular Surlimitations, we have identified the prognostic role of low
serum sodium and NYHA functional class IV as predictors
of outcome. Furthermore, the present study had a small
number of HIV-infected patients and therefore could not
provide definitive information on the effect of HIV infection
in patients with constrictive pericarditis requiring pericar-
diectomy. Finally, the follow-up period included only the
first 30 days after surgery. Longer term studies of the out-
comes are required.CONCLUSIONS
Our study has shown that although effective at relieving
symptoms of constrictive pericarditis, pericardiectomy in
Cape Town was associated with a high perioperative mor-
tality of 14%, mainly related to low output cardiac failure.
Preoperative NYHA class IV and hyponatremia have been
shown to predict perioperative mortality. As expected, the
prevalence of TB constrictive pericarditis was very high,
although the possibility exists that TB as a cause of constric-
tive pericarditis was overreported. We have also shown that
no major differences were present in the clinical profile and
early outcomes of patients with and without HIV infection
undergoing pericardiectomy for constrictive pericarditis.
Our study has illustrated the need for early recourse to peri-
cardiectomy before symptoms deteriorate to NYHA class
IV or severe fluid overload, because a delay will result in
probable myocardial atrophy from chronic myocardial
constriction and lead to worse outcomes. Our findings
also highlight the need to search for methods of reducing
early mortality through improved management of postperi-
cardiectomy low cardiac output syndrome and the need for
better diagnostic techniques of constrictive pericarditis in
our setting.
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FIGURE E1. Comparison of preoperative and 30-day postoperative New
York Heart Association functional status in 73 patients (P<.0001). NYHA,
New York Heart Association.
TABLE E1. Baseline characteristics of 96 study patients with known
HIV status
Characteristic
HIV positive
P valueNo (n ¼ 82) Yes* (n ¼ 14)
Mean age (y) 40.2  16.1 32.1  7.2 .068
Male sex 60 (73.2) 6 (42.9) .024
Cause of constrictive pericarditis .256
TB 75 (91.5) 14 (100)
Other 7 (8.5) 0 (0.0)
Preoperative NYHA class .724
I 2 (2.4) 0 (0.0)
II 25 (31.7) 4 (28.6)
III 36 (43.9) 8 (57.1)
IV 18 (22.0) 2 (14.3)
Symptom duration (mo) 12.6  25.1 5.8  5.1 .316
Hypertension 8 (9.8) 0 (0.0) .222
Diabetes mellitus 2 (2.4) 0 (0.0) .555
Total daily diuretic dosey (mg) 124  115 126  75 .953
Weight (kg) 64.5  12.7 64.6  10.4 .976
SBP (mm Hg) 111  15 109  12 .629
DBP (mm Hg) 70  12 74  9 .154
Pulse (beats/min) 89  16 96  16 .121
Pulsus paradoxus 53 (64.6) 7 (50) .296
Ascites 65 (79.3) 11 (78.6) .953
Diastolic knock 38 (46.3) 8 (57.1) .455
Pleural effusion 63 (76.8) 13 (92.9) .172
Hepatomegaly 71 (86.6) 13 (92.9) .512
Pericardial calcification 17 (20.7) 3 (21.4) .953
Atrial fibrillation 7 (8.5) 0 (0.0) .256
Low QRS amplitude 52 (63.4) 10 (71.4) .562
LVEF (%) 56  11 60  13 .241
Hemoglobin (g/dL) 13.2  1.7 12.1  2.0 .031
Serum sodium (mmol/L) 136  5 137  2 .721
Serum creatinine (mmol/L) 86  25 68  9 .012
Total pericardiectomy 71 (88.8) 13 (92.9) .646
Cardiopulmonary bypass 17 (20.7) 0 (0.0) .06
Postoperative inotrope use 56 (68.3) 8 (57.1) .413
Postoperative ICU stay (d) 3.6  2.6 3.2  1.0 .564
Data presented as mean  standard deviation for continuous variables and n (%) for
categorical variables. HIV, Human immunodeficiency virus; NYHA, New York Heart
Association; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left
ventricular ejection fraction; ICU, intensive care unit; TB, tuberculosis. *Mean CD4
count 284  133 cells/mL. yFurosemide.
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